Peel Therapeutics
Manufacturing · Utah, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
630 S Komas Dr Ste 300, Salt Lake City, ...Phone Number
(650) 464-0747Website
www.peeltx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Peel Therapeutics
Peel Therapeutics is a clinical-stage biotech company focused on translating nature's molecules into innovative medicines for patients suffering from cancer and inflammatory diseases. By leveraging evolutionary biology, the company aims to develop therapies that address a spectrum of challenging health conditions. Their pipeline includes clinical-stage therapeutics, with a particular emphasis on cancer and inflammation. Peel Therapeutics is dedicated to transforming patients' lives through the therapeutic potential of nature's evolutionary outliers.Explore more
Peel Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Peel Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Peel Therapeutics recently announced quarterly report
Peel Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Peel Therapeutics is spiking on competitors!
Click to see if Peel Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Peel Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Peel Therapeutics launches new products
Funding: Get notified immidiatlly once Peel Therapeutics has new funding data
Check if Peel Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Peel Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Peel Therapeutics
Compare insights from companies similar to Peel Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Peel Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Peel Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Peel Therapeutics.
Peel Therapeutics financials insights
Gather financial insights about Peel Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Angel/Seed
$36M
Peel Therapeutics Tech Stack
A closer look at the technologies used by Peel Therapeutics
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Executive Move
Board of Directors
Executive Move
Board of Directors
Funding
Peel Therapeutics News & Media
Peel Therapeutics Closes New Financing Round and Expands Board of Directors to Support Evolution-Based Medicines for Cancer and Inflammation
SALT LAKE CITY, Feb. 23, 2023 /PRNewswire/ -- Peel Therapeutics, an evolutionary-inspired, clinical-stage biotech company, announced recent company updates to support its drug development programs in cancer and inflammation. The company recently secured $9M in funding, bringing its total...Peel Therapeutics Initiates Clinical Trial of PEEL-224 in Patients with Advanced Solid Tumors
PEEL-224 is a small molecule nanoparticle developed for the treatment of cancer SALT LAKE CITY, Aug. 10, 2022 /PRNewswire/ -- Peel Therapeutics, an evolutionary-inspired, clinical-stage biotech company developing medicines for cancer and inflammatory diseases has initiated a...PEEL Therapeutics Preps IND for Prodrug Targeting Chemoresistant Tumors
A novel prodrug to combat high-risk pediatric solid tumors is being developed by PEEL Therapeutics, Inc.PEEL Therapeutics Developing Cancer Drug from Plant Toxin
SALT LAKE CITY, Aug. 24, 2020 /PRNewswire/ -- Researchers have modified a derivative of a plant toxin and linked it to a nanocarrier to create a powerful new therapeutic for childhood tumors. The new drug and its ability to eliminate chemoresistant tumors in mice is described in a new...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Peel Therapeutics
Sign Up For FreeTo access detailed company insights
Peel Therapeutics is a clinical-stage biotech company focused on translating nature's molecules into innovative medicines for patients suffering from cancer and inflammatory diseases. By leveraging evolutionary biology, the company aims to develop therapies that address a spectrum of challenging health conditions. Their pipeline includes clinical-s... Read More
